Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 20, 2020
Feasibility of Treating Adults with Ewing or Ewing-Like Sarcoma with Interval-Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide.
Journal: The oncologist
Published: July 16, 2019
Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 16, 2019
ASO Author Reflections: Chemoradiation for High-Risk Soft Tissue Sarcomas.
Journal: Annals of surgical oncology
Published: October 16, 2018
When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies.
Journal: American journal of nephrology
Published: May 16, 2018
DNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: November 15, 2017
Epirubicin and Ifosfamide with Preoperative Radiation for High-Risk Soft Tissue Sarcomas.
Journal: Annals of surgical oncology
Published: April 28, 2017
What constitutes an "unmet medical need" in oncology? An empirical evaluation of author usage in the biomedical literature.
Journal: Seminars in oncology
Published: April 12, 2017
Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors.
Journal: Cancer discovery
Published: February 08, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026